ClinicalTrials.gg
CompletedNCT06599437Updated Sep 19, 2024

For Patients with Stones in Gallbladder and Bile Duct Stones At the Same Time, Surgical Removal of the Gallbladder with the Laparoscope is Done in the Same Admission Compared to Its Removal After 6 Weeks Following Successful Removel of the Stones from the Bile Ducts by the Side View Endoscope

An interventional study of laparoscopic cholecystectomy and Late laparoscopic cholecystectomy in Choledocholithiasis with Cholecystitis, sponsored by Damanhour Medical National Institute. Completed at 1 site in Egypt. Open to participants aged Up to 80 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Damanhour Medical National Institute · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Dec 2021, registered Sep 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
Up to 80 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if early laparoscopic cholecystectomy is safe and feasible when performed during the same admission for patients with concomitant gallbladder and common bile duct stones after clearance of CBD stones via ERCP in comparison to Late laparoscopic cholecystectomy 6 weeks after ERCP. The main questions it aims to answer are: laparoscopic cholecystectomy

  • Does index laparoscopic cholecystectomy associate with less recurrence of biliary complications?
  • Is index laparoscopic cholecystectomy feasible and safe for the patients in terms of intraoperative difficulties, conversion to open, hospital stay, and postoperative complications than late laparoscopic cholecystectomy? the investigator will compare index laparoscopic cholecystectomy with late laparoscopic cholecystectomy 6 weeks after ERCP to see if index laparoscopic cholecystectomy is safe and feasible and associated with better outcomes.

Participants will:

Come to the outpatient clinic every week after intervention for follow-up for 3 months after surgery.

Read the detailed description

The study population of this randomized controlled trial study is those who underwent CBD stone clearance by ERCP. The included fifty patients were stratified randomly into two groups: early and delayed.

Randomization was done using computer-generated random number sequences in concealed envelopes with a block randomization design. Laparoscopic cholecystectomy is performed on the next day after successful clearance of stones from CBD while, the patient is still admitted, for the early group and postponed 4 to 6 weeks for the delayed group after the patient is discharged home.

Laparoscopic cholecystectomy was performed by the same surgical team for both groups.

02

Conditions studied

  • Choledocholithiasis with Cholecystitis

Browse trials for

Keywords

  • choledocholithiasis
  • ERCP
  • Early cholecystectomy
03

In context

Choledocholithiasis

109 studies on the registry are indexed under Choledocholithiasis; 24 are open to participants now.

This study's enrollment of 50 is below the median of 100 across 76 interventional studies indexed under Choledocholithiasis.

Browse Choledocholithiasis studies →

Lead sponsor

This is the only study on the registry with Damanhour Medical National Institute as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Patients with concomitant gallbladder and common bile duct stone who underwent clearance of common bile duct stones by ERCP

Exclusion Criteria: patients with any of the following:

  • Severe pancreatitis
  • Suspicion of post-ERCP bleeding or perforation,
  • Associated
  • Those in whom ERCP failed to clear the CBD stones
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Early same admission laparoscopic cholecystectomy ( group A)

    Early laparoscopic cholecystectomy is performed on next day within 24 hours after common bile duct stone removal by ERCP.

    Procedure: laparoscopic cholecystectomy

  • Active comparator
    Late laparoscopic cholecystectomy ( group B)

    Late laparoscopic cholecystectomy is performed 6 weeks after common bile duct stones clearance

    Procedure: Late laparoscopic cholecystectomy

Interventions

  • Procedurelaparoscopic cholecystectomy

    Early laparoscopic cholecystectomy in the same admission after atone clearance from the bile ducts via ERCP.

  • ProcedureLate laparoscopic cholecystectomy

    Laparoscopic cholecystectomy is performed 6 weeks after clearance of stones from the common bile duct.

06

What researchers measure

Primary outcomes

  1. recurrence of biliary events

    the occurence of acute cholecystitism biliary colics, common bile duct stonem pancreatitisand cholangitis after ERCP while waiting for laparoscopic cholecystectomy

    Time frame: up to 3 months after surgery

Secondary outcomes

  1. operative time

    time from the first incision of skin to skin closure and completion of surgery

    Time frame: during surgery

  2. pancreatitis

    acute inflammation of the pancreas : abdominal pain, elevated lipase and amylase ( more than 3 folds) and/or findings specific for the pancreatitits on imaging.

    Time frame: 3 months after surgery

  3. conversion to open surgery

    termination of the laparoscopic procedure and perfome the surgery by the conventional open surgery

    Time frame: During surgery

  4. Bleeding

    Intraoperative or postoperative bleeding that requires blood transfusion

    Time frame: during surger and up to 3 weeks

  5. the presence of intraoperative adhesions

    Adhesions around the gallbladder and at the Calot\'s triangle

    Time frame: During surgery

  6. Bile leak

    the leak of bile through the drain or intraabdominally

    Time frame: up to 1 week after surgery

  7. Wound infection

    Any evidence of infection in the wounds : redness, pain or discharge of infected fluids from the wounds

    Time frame: up to 3 months after surgery

  8. hospital stays

    the sum the length of stay after ERCP and laparoscopic cholecystectomy including readmission for complication management

    Time frame: from admission to the end of post operative follow up at 3 months after surgery

  9. post oprative pain

    the degree pain described by the patients after surgery on the visual rating scale

    Time frame: after surgery and up to 3 days

07

Study locations

1 site
  • Damanhur Medical National Institute
    Damanhur, Behira 22951, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06599437
Lead sponsor
Damanhour Medical National Institute
Responsible party
Wael Ahmed El-Dawy (Lecturer of Hepatopacreatobiliary and GI Surgery, Damanhour Medical National Institute) — Principal investigator
First posted
Sep 19, 2024
Start date
Dec 1, 2021
Primary completion
Apr 1, 2024
Completion
Aug 15, 2024
Last update
Sep 19, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion